Qiagen N.V. (FRA:QIA)
Germany · Delayed Price · Currency is EUR | Market Cap | 8.12B |
| Revenue (ttm) | 1.74B |
| Net Income (ttm) | 317.94M |
| Shares Out | n/a |
| EPS (ttm) | 1.44 |
| PE Ratio | 25.54 |
| Forward PE | 18.06 |
| Dividend | 1.42 (3.82%) |
| Ex-Dividend Date | Jul 2, 2025 |
| Volume | 410 |
| Average Volume | 826 |
| Open | 37.19 |
| Previous Close | 37.18 |
| Day's Range | 37.19 - 37.55 |
| 52-Week Range | 32.50 - 46.21 |
| Beta | n/a |
| RSI | 29.07 |
| Earnings Date | Oct 26, 2025 |
About Qiagen
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and... [Read more]
Financial Performance
In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.
Financial numbers in USD Financial StatementsNews
Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Qiagen N.V. (NYSE:QGEN) Bank of America Global Healthcare Conference 2025 September 25, 2025 5:45 AM EDT Company Participants John Gilardi - VP & Head of Corporate Communications Conference Call Part...
QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio
QIAGEN secures CE-IVDR certification for its full QIAstat-Dx portfolio, boosting its diagnostics arm and lifting shares.
Qiagen (QGEN) Earns CE-IVDR Certification for Advanced Diagnostic Panels
Qiagen (QGEN) Earns CE-IVDR Certification for Advanced Diagnostic Panels
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an ex...
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-D...
Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Transcript
Qiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Qiagen NV Launches QIAstat-Dx Rise: A New Era in Automated Syndromic Testing | QGEN stock news
Qiagen NV Launches QIAstat-Dx Rise: A New Era in Automated Syndromic Testing | QGEN stock news
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to ...
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing | QGEN Stock News
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat‑Dx Rise – a version of the QIAstat-Dx automated syndromic testing system that offers unparalled throughput...
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat‑Dx Rise – a version of the QIAsta...
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICT...
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION ...
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICT...
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION ...
Qiagen to raise $750M via non-U.S. offering of convertible bonds
QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICT...
QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION ...
EQS-Adhoc: QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds
EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Issue of Debt QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds 28-Aug-2025 / 07:57 CET/CEST Disclosure of an inside infor...
Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis
Diagnostics now outperform Life Sciences due to academic funding cuts, making Qiagen's defensive profile more attractive in the current market. Qiagen offers stable growth, high profitability, and low...
DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . UBS raise...
Qiagen N.V. (QGEN) Q2 2025 Earnings Call Transcript
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced solid results for Q2 2025 that exceeded the outlook, and increased the fu...
A Look at Qiagen's Upcoming Earnings Report
Qiagen (NYSE: QGEN) will release its quarterly earnings report on Tuesday, 2025-08-05. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Qiagen to report an earning...
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels
VENLO, The Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enri...